Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Comparison of Industry Payments to Physicians and Advanced Practice Clinicians.

Publication ,  Journal Article
Zhang, AD; Anderson, TS
Published in: Jama
December 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Jama

DOI

EISSN

1538-3598

ISSN

0098-7484

Publication Date

December 2022

Volume

328

Issue

24

Start / End Page

2452 / 2455

Related Subject Headings

  • United States
  • Practice Patterns, Physicians'
  • Physicians
  • Industry
  • Humans
  • Health Personnel
  • General & Internal Medicine
  • Financing, Organized
  • Drug Industry
  • Conflict of Interest
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, A. D., & Anderson, T. S. (2022). Comparison of Industry Payments to Physicians and Advanced Practice Clinicians. Jama, 328(24), 2452–2455. https://doi.org/10.1001/jama.2022.20794
Zhang, Audrey D., and Timothy S. Anderson. “Comparison of Industry Payments to Physicians and Advanced Practice Clinicians.Jama 328, no. 24 (December 2022): 2452–55. https://doi.org/10.1001/jama.2022.20794.
Zhang AD, Anderson TS. Comparison of Industry Payments to Physicians and Advanced Practice Clinicians. Jama. 2022 Dec;328(24):2452–5.
Zhang, Audrey D., and Timothy S. Anderson. “Comparison of Industry Payments to Physicians and Advanced Practice Clinicians.Jama, vol. 328, no. 24, Dec. 2022, pp. 2452–55. Epmc, doi:10.1001/jama.2022.20794.
Zhang AD, Anderson TS. Comparison of Industry Payments to Physicians and Advanced Practice Clinicians. Jama. 2022 Dec;328(24):2452–2455.
Journal cover image

Published In

Jama

DOI

EISSN

1538-3598

ISSN

0098-7484

Publication Date

December 2022

Volume

328

Issue

24

Start / End Page

2452 / 2455

Related Subject Headings

  • United States
  • Practice Patterns, Physicians'
  • Physicians
  • Industry
  • Humans
  • Health Personnel
  • General & Internal Medicine
  • Financing, Organized
  • Drug Industry
  • Conflict of Interest